Total Payments
$7,482
2024 Payments
$1,417
Companies
39
Transactions
372
Medicare Patients
1,202
Medicare Billing
$116,516
Payment Breakdown by Category
Food & Beverage$7,468 (99.8%)
Education$14.15 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,468 | 371 | 99.8% |
| Education | $14.15 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,563 | 143 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $963.44 | 47 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $805.11 | 58 | $0 (2024) |
| Boston Scientific Corporation | $425.91 | 5 | $0 (2024) |
| Allergan Inc. | $301.28 | 6 | $0 (2019) |
| Daiichi Sankyo Inc. | $291.56 | 9 | $0 (2021) |
| Phathom Pharmaceuticals, Inc. | $235.31 | 14 | $0 (2024) |
| PFIZER INC. | $227.99 | 6 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $216.77 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $171.03 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,417 | 78 | ABBVIE INC. ($547.17) |
| 2023 | $617.54 | 38 | ABBVIE INC. ($191.80) |
| 2022 | $111.19 | 2 | Boston Scientific Corporation ($89.51) |
| 2021 | $1,449 | 79 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($411.13) |
| 2020 | $1,294 | 76 | AbbVie Inc. ($420.72) |
| 2019 | $1,111 | 36 | AbbVie, Inc. ($506.00) |
| 2018 | $824.12 | 39 | AbbVie, Inc. ($348.85) |
| 2017 | $658.85 | 24 | Allergan Inc. ($182.78) |
All Payment Transactions
372 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/14/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/22/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | CREON (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/01/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.74 | General |
| Category: Neuroscience | ||||||
| 08/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 265 | 332 | $171,266 | $27,135 |
| 2022 | 7 | 198 | 226 | $80,319 | $19,828 |
| 2021 | 13 | 459 | 489 | $190,555 | $43,829 |
| 2020 | 8 | 280 | 291 | $113,930 | $25,724 |
Total Patients
1,202
Total Services
1,338
Medicare Billing
$116,516
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 35 | 35 | $40,483 | $6,562 | 16.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 75 | $16,875 | $4,612 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 55 | 69 | $19,665 | $3,484 | 17.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 31 | $13,206 | $3,138 | 23.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 38 | 38 | $33,244 | $2,370 | 7.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 21 | 21 | $11,046 | $2,173 | 19.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $20,778 | $1,838 | 8.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 26 | 26 | $9,152 | $1,675 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 17 | $6,817 | $1,285 | 18.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 57 | $20,007 | $5,822 | 29.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 56 | 82 | $15,170 | $4,448 | 29.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 13 | 13 | $10,700 | $2,572 | 24.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 28 | 30 | $14,410 | $2,099 | 14.6% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $6,276 | $1,895 | 30.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 21 | 21 | $5,460 | $1,567 | 28.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $8,296 | $1,425 | 17.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 34 | 34 | $29,517 | $6,423 | 21.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 106 | 117 | $10,530 | $6,412 | 60.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 47 | 47 | $10,340 | $5,169 | 50.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 63 | 63 | $38,630 | $4,336 | 11.2% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 48 | 48 | $39,819 | $4,333 | 10.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 26 | 27 | $8,853 | $2,878 | 32.5% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 16 | 18 | $10,268 | $2,856 | 27.8% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 19 | 19 | $13,298 | $2,673 | 20.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 27 | $3,780 | $2,437 | 64.5% |
About Dr. Thomas Geisler, D.O
Dr. Thomas Geisler, D.O is a Internal Medicine healthcare provider based in Erie, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2014. The National Provider Identifier (NPI) number assigned to this provider is 1740608538.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Geisler, D.O has received a total of $7,482 in payments from pharmaceutical and medical device companies, with $1,417 received in 2024. These payments were reported across 372 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,468).
As a Medicare-enrolled provider, Geisler has provided services to 1,202 Medicare beneficiaries, totaling 1,338 services with total Medicare billing of $116,516. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location Erie, PA
- Active Since 03/31/2014
- Last Updated 03/06/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1740608538
Products in Payments
- ENTYVIO (Biological) $615.48
- HUMIRA (Biological) $584.31
- LINZESS (Drug) $490.24
- XIFAXAN (Drug) $473.40
- Humira (Biological) $342.66
- Entyvio (Biological) $244.75
- VOQUEZNA (Drug) $235.31
- TRULANCE (Drug) $229.18
- OCALIVA (Drug) $216.77
- Movantik (Drug) $215.08
- CREON (Drug) $209.38
- Mavyret (Drug) $185.63
- RINVOQ (Biological) $174.40
- XELJANZ (Drug) $169.99
- EXALT Model D (Device) $155.47
- INJECTAFER (Drug) $148.79
- SKYRIZI (Biological) $139.90
- Epclusa (Drug) $124.74
- VIBERZI (Drug) $120.61
- DUPIXENT (Biological) $114.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Erie
Gerald Bishop, Md, MD
Internal Medicine — Payments: $398,351
Internal Medicine $398,351
Orestis Pappas, Md, MD
Internal Medicine — Payments: $241,617
Internal Medicine $241,617
Dr. James Ohr, D.o, D.O
Internal Medicine — Payments: $15,018
Internal Medicine $15,018
Bryant Bojewski, Do, DO
Internal Medicine — Payments: $10,056
Internal Medicine $10,056
Dr. Madalina Opreanu, M.d, M.D
Internal Medicine — Payments: $8,181
Internal Medicine $8,181
Danielle Hansen, Do, DO
Internal Medicine — Payments: $5,901
Internal Medicine $5,901